- Chinese Death Star: The moon cited as the perfect launch pad for ballistic missiles
- Help wanted: Homeland Security plagued by vacancies at the top
- We are not amused: Queen’s protection officers warned to keep ‘sticky fingers’ off the royal cashews
- Unleash the crossbows: Gov. Scott Walker creates new hunting season
- Bubonic plague kills 20 in Madagascar
- G-20 diplomats fell for hacker attack promising nude photos of former French first lady Carla Bruni
- Minnesota guardsman charged with stealing private soldier data for fake IDs
- Florida appeals court rules universities can’t regulate guns
- Vladimir Putin defends Russian conservative values
- Tea Party Patriots call key GOP firing a declaration of war
FENNO: Living CTE diagnosis would be game-changer in head injury studies
Question of the Day
Over the past year and a half, 60 retired NFL veterans traveled to Boston in search of an answer.
Each faced two days of spinal taps to measure proteins, scans, logic examinations, electrophysiological studies, testing for movement and motor skills, cognitive assessment, psychiatric and behavioral interviews, and more.
They’re part of a quiet effort by Boston University's Center for the Study of Traumatic Encephalopathy to develop biomarkers to diagnose and eventually treat chronic traumatic encephalopathy in living patients, the first such study of the disease funded by the National Institutes of Health.
“My sense is, and I say this a lot, I am very confident that within five years we will have the ability to diagnose CTE during life,” said Dr. Robert Stern, the center’s co-founder who directs the study. “That would allow us to answer many critical questions like, is CTE even common? We don’t know. We have no idea if this is really a big public health issue or not.”
There are former players, thousands of them, suing the NFL over head injuries, and public relations campaigns pledging football forever and rules changes and concussion protocols to accompany an army of committees, panels, advisers, partnerships, subcommittees, ambassadors, initiatives, donations and grants.
And never far from the uncertainty swirling around football’s head injuries are those stomach-turning letters: CTE.
The brain-shredding neurodegenerative disease took root in Junior Seau’s brain before he shot himself in 2012. Same with Ray Easterling, who also took his own life last year. Dave Duerson pulled the trigger in 2011. Dozens of other former NFL players were diagnosed.
This is the face — the fear, really — of football’s crossroads. Lives ripped apart. Slides of decimated brain tissue. A disease that robs personalities, damages impulse control, prompts aggression and, in its later stages, resembles Alzheimer’s. A disease that can only be diagnosed by examining brain tissue after death. A disease surrounded by questions.
“Research into CTE is really in its infancy, in spite of what the media portrays,” Stern said. “We know very, very little.”
There’s one nagging constant: Every case of CTE diagnosed after death includes a history of repetitive brain trauma. But not everyone who hits their head repeatedly gets the disease. What is the trigger?
“There’s such a fear out there amongst players, parents that getting your head hit is going to result in your becoming demented,” Stern said. “And yet we don’t know enough about this disease to educate parents, athletes, physicians, policymakers.”
The study isn’t talked about much. But the efforts to unravel CTE’s mysteries could help transform how we view football.
Imagine, for a moment, if a reliable living test is developed. Sure, logic dictates that getting whacked in the head isn’t good. But such a test could provide an objective measure, not educated guesses, of football’s repercussions from youth to high school to college to the pros. When does CTE start? What, if any, genetic factors increase risk? Who is most susceptible? What positions? Length of career? How does concussion history and treatment factor in? Do different tackling techniques or rule changes actually help?
And the ability to diagnose during life, Stern believes, would lead to clinical trials for medication to treat or even prevent the disease.
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
About the Author
- FENNO: Honestly, Mike Shanahan, why should we believe you now?
- Robert Griffin III surprised at being benched by Mike Shanahan
- FENNO: High schooler Chris Cotillo balances MLB scoops, Spanish homework
- Turmoil now a major part of Redskins' game plan
- Mike Shanahan says he'd like to return to Redskins
Latest Blog Entries
By Matt Kibbe
The short-term deal will assure long-term overspending
- Obama's Afghanistan experts stumped on U.S. death toll, war costs during hearing
- NAPOLITANO: A conspiracy so vast
- Comma on!: Twitter erupts over Obama-Castro 'marriage'
- All-out war breaks out in GOP over budget pact
- GOP Rep. Tim Murphy rolls out mental health legislation
- Biden guarantees victory on immigration reform
- Obama takes 'selfie' at Mandela's funeral service
- Selfie at heart of Obama fiasco to stay secret
- White House faces press revolt over access to Obama's South Africa flight
- MALCOLM/REIMER: Over-criminalization undermines respect for legal system
Independent voices from the The Washington Times Communities
Lists of top ten movies, songs, funny moments, fashion statements, automobiles, children's names, stupid celebrity moments, first dates, last dates, weddings, and much, much more.
Communities writers read and review current and past books of note. Also, news and views focusing on print and online media.
An objective, analysis-based perspective of D.C. sports as seen through the eyes of lifelong D.C. sports enthusiast, John Heibel.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow